Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperglycemia and angiogenesis].

Etienne Larger1

  • 1Inserm U.36, Collège de France, 11, place Marcelin Berthelot, 75231 Paris Cedex 05, France. etienne.larger@college-de-france.fr

Medecine Sciences : M/S
|November 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Persistence of Residual Insulin Secretion in Long-Standing Cystic Fibrosis-Related Diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study.

Diabetes & metabolism·2025
Same author

Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor.

Journal of clinical & translational endocrinology·2025
Same author

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.

Cardiovascular diabetology·2025
Same author

Screening for autoimmune atrophic gastritis by serum gastrin measurement in subjects with type 1 diabetes.

Diabetes & metabolism·2025
Same journal

[CREPT: An ally of immunotherapy for the fight against non-small-cell lung cancers].

Medecine sciences : M/S·2026
Same journal

[A new regulatory mechanism of HIF-1α: the ROS-ATM-CHK2 axis at the core of tumor angiogenesis].

Medecine sciences : M/S·2026
Same journal

[Vibrio-host interactions: from the environmental niche to virulence].

Medecine sciences : M/S·2026
Same journal

[RcsF, hyperconnected sentinel of the bacterial envelope].

Medecine sciences : M/S·2026
Same journal

[Single-cell RNA-sequencing: shattering the clone myth].

Medecine sciences : M/S·2026
Same journal

[No, Physarum blobs do not have 720 sexes!]

Medecine sciences : M/S·2026
See all related articles

Chronic hyperglycemia damages vascular endothelial cells, leading to diabetes complications. This damage affects the body's angiogenic response to ischemia, causing organ-specific issues.

Area of Science:

  • Vascular biology
  • Endocrinology
  • Diabetology

Background:

  • Chronic hyperglycemia is a primary driver of vascular complications in diabetes, contributing significantly to morbidity and mortality.
  • Vascular endothelial cells are key targets of hyperglycemia, initiating a cascade of damage.
  • Ischemia, a consequence of vascular damage in diabetes, triggers an angiogenic response.

Purpose of the Study:

  • To investigate the complex effects of chronic hyperglycemia on angiogenesis in diabetes.
  • To understand the organ-specific variations in angiogenic responses to ischemia in diabetic individuals.
  • To explore the molecular mechanisms underlying hyperglycemia's impact on vascular growth factors and endothelial cell behavior.

Main Methods:

  • Analysis of vascular growth factor expression levels under hyperglycemic conditions across different organs and models.

Related Experiment Videos

  • Investigation of direct and indirect effects of hyperglycemia on endothelial cell proliferation.
  • Assessment of hyperglycemia's influence on extracellular matrix and metalloproteinase activity.

    • Main Results:

    • Hyperglycemia variably affects vascular growth factor expression, with context-dependent outcomes.
    • The angiogenic response to chronic ischemia in diabetic patients is dysregulated, showing organ-specific excesses or insufficiencies.
    • Hyperglycemia impacts endothelial cell proliferation, extracellular matrix, and metalloproteinases, contributing to aberrant angiogenesis.

    Conclusions:

    • Chronic hyperglycemia profoundly impacts angiogenesis in diabetes through multifaceted mechanisms.
    • Dysregulated angiogenesis contributes to the heterogeneity of vascular complications in diabetic patients.
    • Further research into these pathways may reveal novel therapeutic targets for diabetic vascular disease.